Trials / Completed
CompletedNCT03525626
Online Mindfulness-based Tic Reduction
Online Mindfulness-based Tic Reduction: Development and Testing (Phase One)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Bowdoin College · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of individuals either do not respond to the current treatments, find them unacceptable, or cannot access them. Thus, it is essential that researchers continue to pursue novel treatment approaches that can also be easily disseminated to those in need. Initial pilot data suggest that a mindfulness-based intervention may be beneficial for adults with tic disorders. In the present study, the researchers aim to further develop this mindfulness-based intervention, adapt it to be delivered online and pilot test the intervention with a small group of participants. The data from this pilot test will inform a subsequent randomized controlled trial comparing online mindfulness-based tic reduction to online psychoeducation, relaxation, and supportive therapy. The specific aim is to determine the feasibility and acceptability of Online Mindfulness-based Tic Reduction in 6 adults with TS or PTD. The researchers hypothesize that Online Mindfulness-based Tic Reduction will be feasible and acceptable to adults with tic disorders as measured by participant satisfaction, qualitative participant feedback, home practice compliance, dropout, and adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Online Mindfulness-based Tic Reduction | 8-week online group mindfulness-based intervention for tics |
Timeline
- Start date
- 2018-04-04
- Primary completion
- 2018-08-07
- Completion
- 2018-08-07
- First posted
- 2018-05-15
- Last updated
- 2019-07-09
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03525626. Inclusion in this directory is not an endorsement.